Health Care & Life Sciences » Pharmaceuticals | GlaxoSmithKline Pharmaceuticals Ltd.

GlaxoSmithKline Pharmaceuticals Ltd. | Cash Flow

Fiscal year is April-March. All values INR Millions.
2013
2015
2016
2017
2018
2019
Net Income before Extraordinaries
6,853
8,076
5,761
4,655
5,222
6,540
Depreciation, Depletion & Amortization
199
254
248
257
377
484
Other Funds
720
-
-
-
-
2,080
Funds from Operations
4,660
5,535
4,054
3,436
3,710
4,944
Changes in Working Capital
118
369
1,244
240
1,648
189
Net Operating Cash Flow
4,542
5,166
2,810
3,195
5,358
4,755
Capital Expenditures
582
1,631
2,323
3,044
4,034
Sale of Fixed Assets & Businesses
279
7
241
464
5,701
Purchase/Sale of Investments
463
1,630
5,668
4,715
3,325
Net Investing Cash Flow
158
6
3,586
2,142
1,651
Cash Dividends Paid - Total
4,214
4,941
6,372
5,097
3,058
Issuance/Reduction of Debt, Net
5
10
7
8
6
Net Financing Cash Flow
4,938
4,951
6,379
5,105
3,064
Net Change in Cash
238
220
16
233
643
Free Cash Flow
3,960
3,534
486
151
1,325
Other Sources
-
-
-
7
7
Other Uses
2
-
-
-
-

About GlaxoSmithKline Pharmaceuticals

View Profile
Address
GSK House
Mumbai Maharashtra 400030
India
Employees -
Website http://www.gsk-india.com
Updated 07/08/2019
GlaxoSmithKline Pharmaceuticals Ltd. engages in the business of manufacturing, distributing and trading in pharmaceuticals. It specializes in prescription medicines and vaccines. Its prescription medicines range across therapeutic areas such as anti-infective, dermatology, gynecology, diabetes, cardiovascular disease and respiratory diseases.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.